Navigation Links
Quantum dots deliver Vitamin D to tumors for possible inflammatory breast cancer treatment
Date:2/1/2013

Philadelphia, Pa. The shortened daylight of a Maine winter may make for long, dark nights but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer.

The new approach enlists the active form of Vitamin D3, called calcitriol, which is delivered therapeutically by quantum dots. Quantum dots are an engineered light-emitting nanoscale delivery vehicle. This new preliminary work shows the dots can be used to rapidly move high concentrations of calcitriol to targeted tumor sites where cancer cells accumulate, and also through the lymph system where the cancer spreads. With this approach, the calcitriol can fight on multiple fronts and the targeted location can be visualized with an imaging system tracking the quantum dots. The research will be presented at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.

University of Delaware cancer researcher Anja Nohe was living in Maine when she first received funding from the Maine Cancer Foundation to determine the effect of calcitriol on breast cancer cells. Reading cancer literature helped her make connections between cancer, vitamin D, and the daylight regime of higher latitudes. "By talking with talented colleagues about these ideas, the foundation was set for the current project," she says. After moving to the University of Delaware, she began working with Kenneth Van Golen, "an expert in the biology of IBC," to evaluate calcitriol.

Compared to other forms of breast cancer, IBC is especially difficult to treat. It has a five-year survival rate of 40% versus 87% for all other breast cancers. A big part of what makes IBC treatment difficult is its multi-site growth pattern. Current aggressive treatments such as combinations of chemotherapy, surgery and radiation, have failed to significantly improve IBC survival rates.

This early experimental work on mice is encouraging because data show calcitriol can inhibit invasion and migration of SUM149 cells, an IBC cell line. "New IBC therapies are urgently needed, which is why the goal of my work is to find a successful treatment for inflammatory breast cancer, especially one with fewer side effects," Nohe says.


'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
240-290-5606
American Institute of Physics
Source:Eurekalert

Related biology news :

1. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates
2. High Brightness Tetrapod Quantum Dots Developed
3. Quantum communication: Each photon counts
4. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
5. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
6. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
7. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial
8. Cancerous tumors deliver pro-metastatic information in secreted vesicles
9. iView Systems iTrak® version 5.5 delivers optimized Incident Reporting
10. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
11. OSCs Oakley Cluster delivers on performance efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/20/2016)... , Dec. 20, 2016 The rising ... rental and leasing is stoking significant interest in ... frequency technology, Bluetooth low energy (BLE), biometrics and ... the next wave of wireless technologies in the ... system to advanced access systems opens the market ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... LANSING, Mich. , Jan. 24, 2017  Neogen ... it had terminated its agreement with SenesTech Incorporated (NASDAQ: ... marketing of a rodenticide being developed by SenesTech. The ... to the time when the SenesTech product was approved ... final EPA approval provided that the product could only ...
(Date:1/24/2017)... Jan. 24, 2017   Bracket , a leading ... the addition of Jennifer Peters to its ... and General Manager for the Scientific Services division. In ... work in Rater Training, Quality Assurance, and Electronic Clinical ... strong skillset and demonstrated record building technology-based businesses in ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... solutions, announces the appointment of Steven F. McAllister as Executive Vice President and ... in both the U.S. and international markets. Beginning his career at Howmedica, Inc., ...
(Date:1/24/2017)... ... January 24, 2017 , ... Nor-Tech’s leading-edge demo ... with user-friendly bootable Intel KNL. , Currently Cal Tech researchers are testing ... cluster. The demo cluster is a no-cost, no-strings opportunity for current and prospective ...
Breaking Biology Technology: